Kidney Patients Not On Dialysis, FDA Advisers Recommend Continuation Of Aranesp (Darbepoetin Alfa)
Links shared publicly online about this topic.
- 791total visits
Kidney Patients Not On Dialysis, FDA Advisers Recommend Continuation Of Aranesp (Darbepoetin Alfa)
An FDA Advisory Committee has recommended the continued use of Aranesp (Darbepoetin alfa), a synthetic form of erythropoietin used to treat anemia in patients with mild to moderate chronic (long-t
View full resource at medicalnewstoday.com
Tags: Anemia Medication, Urinary System, Dialysis, FDA, Aranesp, Procrit, Eprex, Epogen
Most Recently Shared on October 19, 2010 at 3:05 am By:
Kidney Patients Not On Dialysis, FDA Advisers Recommend Continuation Of Aranesp (Darbepoetin Alfa) http://mnt.to/3Lpr #regulatory
Also Shared By:
Advertisement
medical_tweets
@medical_tweets
Kidney Patients Not On Dialysis, FDA Advisers Recommend Continuation Of Aranesp (Darbepoetin Alfa) An FDA Advisory Comm.. http://dld.bz/2kd8
1 year ago...